Which has the lower trailing P/E, ABBV or BMY?

BMY has the lower trailing P/E: ABBV trades at 129.20 and BMY at 17.57. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or BMY?

Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus BMY at 2.52%.

Does ABBV or BMY pay a bigger dividend?

ABBV yields 2.56% and BMY yields 4.00% based on trailing dividends and the latest price.

Is ABBV or BMY more profitable?

BMY runs the higher net margin — ABBV at 5.79% versus BMY at 15.01%.

How have ABBV and BMY total returns compared?

Over the past 10 years, ABBV delivered 19.90% and BMY delivered 2.02% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Bristol-Myers Squibb Company (BMY)

A side-by-side comparison of AbbVie Inc. and Bristol-Myers Squibb Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$465.51B

$263.48HealthcareAt close: Jul 28, 2026, 4:00 PM ET

BMY

Bristol-Myers Squibb Company

$129.88B

$63.60HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — ABBV vs BMY

growth of $100 · dividends reinvested · last 14y

ABBV +1197.1%BMY +209.2%ABBV compounded faster

ABBV BMY

ABBV vs BMY: by the numbers

•ABBV is the larger company ($465.51B vs $129.88B market cap).
•BMY trades at the lower trailing earnings multiple (17.57 vs 129.20 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (15.01% vs 5.79% net margin).
•ABBV grew revenue faster over the past five years (4.59% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.00% vs 2.56%).

Metrics side by side

Valuation

Metric	ABBV	BMY
P/E ratio	129.20	17.57
Forward P/E	N/A	9.86
P/S ratio	7.44	2.64
P/B ratio	17.00	6.37
PEG ratio	N/A	1.87
EV / EBITDA	20.92	10.34
FCF yield	4.46%	9.31%

Profitability

Metric	ABBV	BMY
Gross margin	70.68%	68.75%
Operating margin	27.60%	25.67%
Net margin	5.79%	15.01%
ROE	13.23%	36.25%
ROIC	12.97%	13.90%

Dividends

Metric	ABBV	BMY
Dividend yield	2.56%	4.00%
Payout ratio	284.39%	72.25%

Growth (annualized)

Metric	ABBV	BMY
Revenue CAGR (5Y)	4.59%	2.52%
EPS CAGR (5Y)	-2.79%	9.38%
FCF CAGR (5Y)	3.24%	-2.50%
Total return CAGR (5Y)	21.73%	2.73%

Frequently asked

Which has the lower trailing P/E, ABBV or BMY?: BMY has the lower trailing P/E: ABBV trades at 129.20 and BMY at 17.57. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or BMY?: Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus BMY at 2.52%.
Does ABBV or BMY pay a bigger dividend?: ABBV yields 2.56% and BMY yields 4.00% based on trailing dividends and the latest price.
Is ABBV or BMY more profitable?: BMY runs the higher net margin — ABBV at 5.79% versus BMY at 15.01%.
How have ABBV and BMY total returns compared?: Over the past 10 years, ABBV delivered 19.90% and BMY delivered 2.02% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full BMY analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Bristol-Myers Squibb P/E ratio AbbVie dividend yield Bristol-Myers Squibb dividend yield AbbVie ROE Bristol-Myers Squibb ROE AbbVie operating margin Bristol-Myers Squibb operating margin AbbVie revenue growth Bristol-Myers Squibb revenue growth AbbVie free cash flow Bristol-Myers Squibb free cash flow

AbbVie & Bristol-Myers Squibb appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.